Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases

Journal of Aging Research

Volumn 2013, Issue , 2013, Pages

  Markiewicz, Margaret ^a   Richard, Erin ^b   Marks, Natalia ^c   Ludwicka Bradley, Anna ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b School of Business   (United States)

^c MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; CADHERIN; CALCIUM; CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE ACTIVATED RECEPTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

AGING; ANGIOGENESIS; APOPTOSIS; BLOOD CLOTTING; BLOOD VESSEL INJURY; BRAIN ISCHEMIA; CELL ACTIVATION; CELL MEMBRANE; CELL VACUOLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ESTROGEN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

EID: 84888881590     PISSN: 20902204     EISSN: 20902212     Source Type: Journal    
DOI: 10.1155/2013/734509     Document Type: Review

References (120)

1. Liu W., Reinmuth N., Stoeltzing O., Parikh A. A., Fan F., Ahmad S. A., Jung Y. D., Ellis L. M., Antiangiogenic therapy targeting factors that enhance endothelial cell survival. Seminars in Oncology 2002 29 3 96 103 2-s2.0-0036315547 (Pubitemid 34816071)
2. Endemann D. H., Schiffrin E. L., Endothelial dysfunction. Journal of the American Society of Nephrology 2004 15 8 1983 1992 2-s2.0-3543133645 10.1097/01.ASN.0000132474.50966.DA (Pubitemid 39031337)
3. Burger D., Montezano A. C., Nishigaki N., He Y., Carter A., Touyz R. M., Endothelial microparticle formation by angiotensin II is mediated via ang II receptor type I/NADPH Oxidase/rho kinase pathways targeted to lipid rafts. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 8 1898 1907 2-s2.0-80051545455 10.1161/ATVBAHA.110.222703
4. Leroyer A. S., Anfosso F., Lacroix R., Sabatier F., Simoncini S., Njock S. M., Jourde N., Brunet P., Camoin-Jau L., Sampol J., Dignat-George F., Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thrombosis and Haemostasis 2010 104 3 456 463 2-s2.0-77956621829 10.1160/TH10-02-0111
5. Owens A. P., MacKman N., Microparticles in hemostasis and thrombosis. Circulation Research 2011 108 10 1284 1297 2-s2.0-79957493898 10.1161/CIRCRESAHA.110.233056
6. Boulanger C. M., Microparticles, vascular function and hypertension. Current Opinion in Nephrology and Hypertension 2010 19 2 177 180 2-s2.0-76749103366 10.1097/MNH.0b013e32833640fd
7. Boulanger C. M., Dignat-George F., Microparticles: an introduction. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1 2 3 2-s2.0-78650860702 10.1161/ATVBAHA.110.220095
8. Moulin V. J., Mayrand D., Messier H., Martinez M. C., Lopez-Vallé C. A., Genest H., Shedding of microparticles by myofibroblasts as mediator of cellular cross-talk during normal wound healing. Journal of Cellular Physiology 2010 225 3 734 740 2-s2.0-77957824532 10.1002/jcp.22268
9. Wolf P., The nature and significance of platelet products in human plasma. The British Journal of Haematology 1967 13 3 269 288 2-s2.0-0014082202
10. Berckmans R. J., Nieuwland R., Böing A. N., Romijn F. P. H. T. M., Hack C. E., Sturk A., Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thrombosis and Haemostasis 2001 85 4 639 646 2-s2.0-0035070809 (Pubitemid 32293699)
11. Leroyer A. S., Isobe H., Lesèche G., Castier Y., Wassef M., Mallat Z., Binder B. R., Tedgui A., Boulanger C. M., Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. Journal of the American College of Cardiology 2007 49 7 772 777 2-s2.0-33846895247 10.1016/j.jacc.2006.10.053 (Pubitemid 46240708)
12. Meziani F., Tesse A., Andriantsitohaina R., Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacological Reports 2008 60 1 75 84 2-s2.0-42549113878 (Pubitemid 351586545)
13. Chironi G. N., Boulanger C. M., Simon A., Dignat-George F., Freyssinet J., Tedgui A., Endothelial microparticles in diseases. Cell and Tissue Research 2009 335 1 143 151 2-s2.0-57749208172 10.1007/s00441-008-0710-9
14. Mause S. F., Weber C., Microparticles: protagonists of a novel communication network for intercellular information exchange. Circulation Research 2010 107 9 1047 1057 2-s2.0-78349285166 10.1161/CIRCRESAHA.110.226456
15. Horstman L. L., Ahn Y. S., Platelet microparticles: a wide-angle perspective. Critical Reviews in Oncology/Hematology 1999 30 2 111 142 2-s2.0-0032953002 10.1016/S1040-8428(98)00044-4 (Pubitemid 29232249)
16. Hussein M. N. A., Meesters E. W., Osmanovic N., Romijn F. P. H. T. M., Nieuwland R., Sturk A., Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. Journal of Thrombosis and Haemostasis 2003 1 11 2434 2443 2-s2.0-3042614111 10.1046/j.1538-7836.2003. 00455.x
17. Combes V., Simon A., Grau G., Arnoux D., Camoin L., Sabatier F., Mutin M., Sanmarco M., Sampol J., Dignat-George F., In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. Journal of Clinical Investigation 1999 104 1 93 102 2-s2.0-0032694867 (Pubitemid 29534349)
18. Martínez M. C., Tesse A., Zobairi F., Andriantsitohaina R., Shed membrane microparticles from circulating and vascular cells in regulating vascular function. The American Journal of Physiology-Heart and Circulatory Physiology 2005 288 3 H1004 H1009 2-s2.0-13944276772 10.1152/ajpheart.00842.2004 (Pubitemid 40269999)
19. Diamant M., Tushuizen M. E., Sturk A., Nieuwland R., Cellular microparticles: new players in the field of vascular disease? European Journal of Clinical Investigation 2004 34 6 392 401 2-s2.0-3042716498 10.1111/j.1365-2362.2004.01355.x (Pubitemid 38859560)
20. -2012 NHLBI Fact Book,. Chapter 4, Disease Statistics: Prevalence of Common Cardiovascular and Lung Diseases, US., 2007-2011
21. Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases
22. Belchetz P. E., Hormonal treatment of postmenopausal women. The New England Journal of Medicine 1994 330 15 1062 1071 2-s2.0-0028220251 10.1056/NEJM199404143301508 (Pubitemid 24106566)
23. Grodstein F., Stampfer M. J., Manson J. E., Colditz G. A., Willett W. C., Rosner B., Speizer F. E., Hennekens C. H., Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. The New England Journal of Medicine 1996 335 7 453 461 2-s2.0-0029759025 10.1056/NEJM199608153350701 (Pubitemid 26269944)
24. Dick S. E., DeWitt D. E., Anawalt B. D., Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia. The American Journal of Managed Care 2002 8 1 95 104 2-s2.0-0036162556 (Pubitemid 34116302)
25. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E., Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. The Journal of the American Medical Association 1998 280 7 605 613 2-s2.0-0032547326 10.1001/jama.280.7.605 (Pubitemid 28502636)
26. Viscoli C. M., Brass L. M., Kernan W. N., Sarrel P. M., Suissa S., Horwitz R. I., A clinical trial of estrogen-replacement therapy after ischemic stroke. The New England Journal of Medicine 2001 345 17 1243 1249 2-s2.0-0035950682 10.1056/NEJMoa010534 (Pubitemid 34951488)
27. Simoncini T., Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging. Climacteric 2009 12 1 6 11 2-s2.0-73949087372 10.1080/13697130902986385
28. Morel O., Toti F., Hugel B., Bakouboula B., Camoin-Jau L., Dignat-George F., Freyssinet J., Procoagulant microparticles: disrupting the vascular homeostasis equation? Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 12 2594 2604 2-s2.0-33751169794 10.1161/01.ATV.0000246775.14471.26
29. Bretelle F., Sabatier F., Desprez D., Camoin L., Grunebaum L., Combes V., D'Ercole C., Dignat-George F., Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thrombosis and Haemostasis 2003 89 3 486 492 2-s2.0-0037342076 (Pubitemid 36329239)
30. VanWijk M. J., Boer K., Berckmans R. J., Meijers J. C. M., van der Post J. A. M., Sturk A., VanBavel E., Nieuwland R., Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents. Thrombosis and Haemostasis 2002 88 3 415 420 2-s2.0-0036714380 (Pubitemid 35021598)
31. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P. G., Freyssinet J., Tedgui A., Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000 101 8 841 843 2-s2.0-0033999142 (Pubitemid 30117876)
32. Preston R. A., Jy W., Jimenez J. J., Mauro L. M., Horstman L. L., Valle M., Aime G., Ahn Y. S., Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003 41 2 211 217 2-s2.0-0037315391 10.1161/01.HYP.0000049760.15764.2D (Pubitemid 36204891)
33. Boulanger C. M., Scoazec A., Ebrahimian T., Henry P., Mathieu E., Tedgui A., Mallat Z., Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001 104 22 2649 2652 2-s2.0-0035960621 (Pubitemid 33108128)
34. Burger D., Touyz R. M., Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. Journal of the American Society of Hypertension 2012 6 2 85 99 2-s2.0-84858706220 10.1016/j.jash.2011.11.003
35. Shet A. S., Aras O., Gupta K., Hass M. J., Rausch D. J., Saba N., Koopmeiners L., Key N. S., Hebbel R. P., Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003 102 7 2678 2683 2-s2.0-0141705303 10.1182/blood-2003-03-0693 (Pubitemid 37193612)
36. Horstman L. L., Jy W., Jimenez J. J., Ahn Y. S., Endothelial microparticles as markers of endothelial dysfunction. Frontiers in Bioscience 2004 9 1118 1135 2-s2.0-2442661930 (Pubitemid 39060833)
37. Jimenez J. J., Jy W., Mauro L. M., Soderland C., Horstman L. L., Ahn Y. S., Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thrombosis Research 2003 109 4 175 180 2-s2.0-0037709857 10.1016/S0049-3848(03)00064-1 (Pubitemid 36712905)
38. Tramontano A. F., Lyubarova R., Tsiakos J., Palaia T., Deleon J. R., Ragolia L., Circulating endothelial microparticles in diabetes mellitus. Mediators of Inflammation 2010 2010 8 2-s2.0-77954549540 10.1155/2010/250476 250476
39. van Ierssel S. H., van Craenenbroeck E. M., Conraads V. M., van Tendeloo V. F., Vrints C. J., Jorens P. G., Hoymans V. Y., Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. Thrombosis Research 2010 125 4 332 339 2-s2.0-77949567837 10.1016/j.thromres.2009.12.019
40. Yong P. J., Koh C. H., Shim W., Endothelial microparticles: missing link in endothelial dysfunction? European Journal of Preventive Cardiology 2013 20 3 496 512 10.1177/2047487312445001
41. Huber J., Vales A., Mitulovic G., Blumer M., Schmid R., Witztum J. L., Binder B. R., Leitinger N., Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 1 101 107 2-s2.0-0036141870 10.1161/hq0102.101525 (Pubitemid 34076239)
42. VanWijk M. J., VanBavel E., Sturk A., Nieuwland R., Microparticles in cardiovascular diseases. Cardiovascular Research 2003 59 2 277 287 2-s2.0-0142122248 10.1016/S0008-6363(03)00367-5 (Pubitemid 37272022)
43. MacKman N., Davis G. E., Blood coagulation and blood vessel development: is tissue factor the missing link? Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 11 2364 2366 2-s2.0-80054923152 10.1161/ATVBAHA.111.236703
44. Rautou P., Leroyer A. S., Ramkhelawon B., Devue C., Duflaut D., Vion A., Nalbone G., Castier Y., Leseche G., Lehoux S., Tedgui A., Boulanger C. M., Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circulation Research 2011 108 3 335 343 2-s2.0-79751537634 10.1161/CIRCRESAHA.110.237420
45. Ludwicka-Bradley A., Tourkina E., Suzuki S., Tyson E., Bonner M., Fenton J. W. II, Hoffman S., Silver R. M., Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C- γ activation. The American Journal of Respiratory Cell and Molecular Biology 2000 22 2 235 243 2-s2.0-0034034708 (Pubitemid 30351487)
46. Curtis A. M., Wilkinson P. F., Gui M., Gales T. L., Hu E., Edelberg J. M., p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles. Journal of Thrombosis and Haemostasis 2009 7 4 701 709 2-s2.0-63049118579 10.1111/j.1538-7836.2009.03304.x
47. Peterson D. B., Sander T., Kaul S., Wakim B. T., Halligan B., Twigger S., Pritchard K. A. Jr., Oldham K. T., Ou J., Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 2008 8 12 2430 2446 2-s2.0-48249091633 10.1002/pmic.200701029
48. Franchini M., Hemostasis and aging. Critical Reviews in Oncology/Hematology 2006 60 2 144 151 2-s2.0-33750996725 10.1016/j.critrevonc. 2006.06.004 (Pubitemid 44740495)
49. Zimmerman G. A., Thinking small, but with big league consequences: procoagulant microparticles in the alveolar space. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2009 297 6 L1033 L1034 2-s2.0-71949108131 10.1152/ajplung.00335.2009
50. Brodsky S. V., Malinowski K., Golightly M., Jesty J., Goligorsky M. S., Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 2002 106 18 2372 2378 2-s2.0-0037195054 10.1161/01.CIR.0000033972.90653.AF (Pubitemid 35244740)
51. Rerolle J. P., Hertig A., Nguyen G., Sraer J. D., Rondeau E. P., Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney International 2000 58 5 1841 1850 2-s2.0-0033752717 10.1046/j.1523-1755.2000.00355.x
52. Philippova M., Suter Y., Toggweiler S., Schoenenberger A. W., Joshi M. B., Kyriakakis E., Erne P., Resink T. J., T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis. European Heart Journal 2011 32 6 760 771 2-s2.0-79952856179 10.1093/eurheartj/ehq206
53. Krupiczojc M. A., Scotton C. J., Chambers R. C., Coagulation signalling following tissue injury: focus on the role of factor Xa. International Journal of Biochemistry and Cell Biology 2008 40 6-7 1228 1237 2-s2.0-43049113102 10.1016/j.biocel.2008.02.026
54. Chambers R. C., Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? The British Journal of Pharmacology 2008 153 supplement 1 S367 S378 2-s2.0-40349098060 10.1038/sj.bjp.0707603 (Pubitemid 351340998)
55. Ludwicka-Bradley A., Bogatkevich G., Silver R. M., Thrombin-mediated cellular events in pulmonary fibrosis associated with systemic sclerosis (scleroderma). Clinical and Experimental Rheumatology 2004 22 3, supplement 33 S38 S46 2-s2.0-4444252776 (Pubitemid 39162034)
56. Bachhuber B. G., Sarembock I. J., Gimple L. W., Owens G. K., α -thrombin induces transforming growth factor- β 1 mRNA and protein in cultured vascular smooth muscle cells via a proteolytically activated receptor. Journal of Vascular Research 1997 34 1 41 48 2-s2.0-0031044094 (Pubitemid 27105913)
57. Ludwicka-Bradley A., Silver R. M., Bogatkevich G. S., Coagulation and autoimmunity in scleroderma interstitial lung disease. Seminars in Arthritis and Rheumatism 2011 41 2 212 222 2-s2.0-80755136673 10.1016/j.semarthrit.2010.10. 002
58. Sapet C., Simoncini S., Loriod B., Puthier D., Sampol J., Nguyen C., Dignat-George F., Anfosso F., Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006 108 6 1868 1876 2-s2.0-33748705954 10.1182/blood-2006-04- 014175 (Pubitemid 44394996)
59. Simoncini S., Njock M., Robert S., Camoin-Jau L., Sampol J., Harlé J., Nguyen C., Dignat-George F., Anfosso F., Trail/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation. Circulation Research 2009 104 8 943 951 2-s2.0-65449187868 10.1161/CIRCRESAHA.108.183285
60. Ueba T., Haze T., Sugiyama M., Higuchi M., Asayama H., Karitani Y., Nishikawa T., Yamashita K., Nagami S., Nakayama T., Kanatani K., Nomura S., Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thrombosis and Haemostasis 2008 100 2 280 285 2-s2.0-48949093686 10.1160/TH07-11-0668
61. Takeya H., Gabazza E. C., Aoki S., Ueno H., Suzuki K., Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells. Blood 2003 102 5 1693 1700 2-s2.0-0042942985 10.1182/blood-2002-11-3607 (Pubitemid 37022562)
62. Martinez M. C., Andriantsitohaina R., Microparticles in angiogenesis: therapeutic potential. Circulation Research 2011 109 1 110 119 2-s2.0-79959969458 10.1161/CIRCRESAHA.110.233049
63. Obinata H., Hla T., Sphingosine 1-phosphate in coagulation and inflammation. Seminars in Immunopathology 2012 34 1 73 91 2-s2.0-84859701240 10.1007/s00281-011-0287-3
64. Markiewicz M., Nakerakanti S. S., Kapanadze B., Ghatnekar A., Trojanowska M., Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. Microcirculation 2011 18 1 1 11 2-s2.0-78650571743 10.1111/j.1549-8719.2010.00058.x
65. Jy W., Jimenez J. J., Mauro L. M., Horstman L. L., Cheng P., Ahn E. R., Bidot C. J., Ahn Y. S., Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. Journal of Thrombosis and Haemostasis 2005 3 6 1301 1308 2-s2.0-24944446840 10.1111/j.1538-7836.2005.01384.x (Pubitemid 41725256)
66. Sabatier F., Roux V., Anfosso F., Camoin L., Sampol J., Dignat-George F., Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002 99 11 3962 3970 2-s2.0-0036624734 10.1182/blood.V99.11.3962 (Pubitemid 35332035)
67. Jy W., Minagar A., Jimenez J. J., Sheremata W. A., Mauro L. M., Horstman L. L., Bidot C., Ahn Y. S., Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Frontiers in Bioscience 2004 9 3137 3144 2-s2.0-13344276666
68. Cesari M., Pahor M., Incalzi R. A., Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovascular Therapeutics 2010 28 5 e72 e91 2-s2.0-77956413611 10.1111/j.1755-5922.2010.00171.x
69. Epstein C. J., Martin G. M., Schultz A. L., Motulsky A. G., Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine 1966 45 3 177 221 2-s2.0-0013907774
70. Lacroix R., Dignat-George F., Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thrombosis Research 2012 129 supplement 2 S27 S29 2-s2.0-84859802636 10.1016/j.thromres.2012.02.025
71. van Veen S. Q., Meijers J. C. M., Levi M., van Gulik T. M., Boermeester M. A., Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis. Shock 2007 27 5 534 541 2-s2.0-34247223233 10.1097/01.shk.0000246897.27574.1b (Pubitemid 46626081)
72. Tita-Nwa F., Bos A., Adjei A., Ershler W. B., Longo D. L., Ferrucci L., Correlates of D-dimer in older persons. Aging-Clinical and Experimental Research 2010 22 1 20 23 2-s2.0-77951837112
73. Song Y., Shen H., Schenten D., Shan P., Lee P. J., Goldstein D. R., Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 1 103 109 2-s2.0-83655163745 10.1161/ATVBAHA.111.236349
74. Folkman J., Shing Y., Angiogenesis. The Journal of Biological Chemistry 1992 267 16 10931 10934 2-s2.0-0026639806
75. Djonov V., Schmid M., Tschanz S. A., Burri P. H., Intussusceptive angiogenesis. Its role in embryonic vascular network formation. Circulation Research 2000 86 3 286 292 2-s2.0-0033964164 (Pubitemid 30108822)
76. Li J., Zhang Y., Kirsner R. S., Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microscopy Research and Technique 2003 60 1 107 114 2-s2.0-0037223577 10.1002/jemt.10249 (Pubitemid 36055239)
77. Brodsky S. V., Zhang F., Nasjletti A., Goligorsky M. S., Endothelium-derived microparticles impair endothelial function in vitro. The American Journal of Physiology-Heart and Circulatory Physiology 2004 286 5 H1910 H1915 2-s2.0-1942533438 10.1152/ajpheart.01172.2003 (Pubitemid 38525481)
78. Mateos-Caceres P. J., Zamorano-Leon J. J., Rodriguez-Sierra P., Macaya C., Lopez-Farre A. J., New and old mechanisms associated with hypertension in the elderly. International Journal of Hypertension 2012 2012 10 150107 10.1155/2012/150107
79. Jung K. H., Chu K., Lee S. T., Park H. K., Bahn J. J., Kim D. H., Kim J. H., Kim M., Lee S. K., Roh J. K., Circulating endothelial microparticles as a marker of cerebrovascular disease. Annals of Neurology 2009 66 2 191 199 2-s2.0-70149092328 10.1002/ana.21681
80. Mezentsev A., Merks R. M. H., O'Riordan E., Chen J., Mendelev N., Goligorsky M. S., Brodsky S. V., Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. The American Journal of Physiology-Heart and Circulatory Physiology 2005 289 3 H1106 H1114 2-s2.0-23944476083 10.1152/ajpheart.00265.2005 (Pubitemid 41208953)
81. Davizon P., López J. A., Microparticles and thrombotic disease. Current Opinion in Hematology 2009 16 5 334 341 2-s2.0-69549116335 10.1097/MOH.0b013e32832ea49c
82. Ballard V. L. T., Edelberg J. M., Targets for regulating angiogenesis in the ageing endothelium. Expert Opinion on Therapeutic Targets 2007 11 11 1385 1399 2-s2.0-36749102062 10.1517/14728222.11.11.1385 (Pubitemid 350213814)
83. Gates P. E., Strain W. D., Shore A. C., Human endothelial function and microvascular ageing. Experimental Physiology 2009 94 3 311 316 2-s2.0-60349129368 10.1113/expphysiol.2008.043349
84. Burger D., Kwart D. G., Montezano A. C., Read N. C., Kennedy C. R., Thompson C. S., Touyz R. M., Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence. Journal of the American Heart Association 2012 1 3 e001842
85. Amabile N., Rautou P., Tedgui A., Boulanger C. M., Microparticles: key protagonists in cardiovascular disorders. Seminars in Thrombosis and Hemostasis 2010 36 8 907 916 2-s2.0-78149288056 10.1055/s-0030-1267044
86. Mallat Z., Hugel B., Ohan J., Lesèche G., Freyssinet J., Tedgui A., Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999 99 3 348 353 2-s2.0-0032891440 (Pubitemid 29051259)
87. Lacroix R., Sabatier F., Mialhe A., Basire A., Pannell R., Borghi H., Robert S., Lamy E., Plawinski L., Camoin-Jau L., Gurewich V., Angles-Cano E., Dignat-George F., Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 2007 110 7 2432 2439 2-s2.0-34948812510 10.1182/blood-2007-02-069997 (Pubitemid 47523164)
88. Thomashow M. A., Shimbo D., Parikh M. A., Hoffman E. A., Vogel-Claussen J., Hueper K., Fu J., Liu C. Y., Bluemke D. A., Ventetuolo C. E., Doyle M. F., Barr R. G., Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The multiethnic study of atherosclerosis chronic obstructive pulmonary disease study. The American Journal of Respiratory and Critical Care Medicine 2013 188 1 60 68 10.1164/rccm.201209-1697OC
89. Edelberg J. M., Reed M. J., Aging and angiogenesis. Frontiers in Bioscience 2003 8 s1199 s1209 2-s2.0-3142760350 (Pubitemid 38925381)
90. Hill J. M., Zalos G., Halcox J. P. J., Schenke W. H., Waclawiw M. A., Quyyumi A. A., Finkel T., Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. The New England Journal of Medicine 2003 348 7 593 600 2-s2.0-0037434561 10.1056/NEJMoa022287 (Pubitemid 36204953)
91. Heiss C., Keymel S., Niesler U., Ziemann J., Kelm M., Kalka C., Impaired progenitor cell activity in age-related endothelial dysfunction. Journal of the American College of Cardiology 2005 45 9 1441 1448 2-s2.0-18144377085 10.1016/j.jacc.2004.12.074 (Pubitemid 40615616)
92. Markiewicz M., Asano Y., Znoyko S., Gong Y., Watson D. K., Trojanowska M., Distinct effects of gonadectomy in male and female mice on collagen fibrillogenesis in the skin. Journal of Dermatological Science 2007 47 3 217 226 2-s2.0-34447573705 10.1016/j.jdermsci.2007.05.008 (Pubitemid 47077899)
93. Koike T., Vernon R. B., Gooden M. D., Sadoun E., Reed M. J., Inhibited angiogenesis in aging: a role for TIMP-2. Journals of Gerontology A 2003 58 9 798 805 2-s2.0-0141642198 (Pubitemid 37221876)
94. Bagot C. N., Marsh M. S., Whitehead M., Sherwood R., Roberts L., Patel R. K., Arya R., The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy. Journal of Thrombosis and Haemostasis 2010 8 8 1736 1744 2-s2.0-77958606355 10.1111/j.1538-7836.2010.03953.x
95. Morales D. E., McGowan K. A., Grant D. S., Maheshwari S., Bhartiya D., Cid M. C., Kleinman H. K., Schnaper H. W., Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995 91 3 755 763 2-s2.0-0028815410
96. Schnaper H. W., McGowan K. A., Kim-Schulze S., Cid M. C., oestrogen and endothelial cell angiogenic activity. Clinical and Experimental Pharmacology and Physiology 1996 23 3 247 250 2-s2.0-0029941355 (Pubitemid 26171510)
97. Venkov C. D., Rankin A. B., Vaughan D. E., Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996 94 4 727 733 2-s2.0-0029738659 (Pubitemid 26289229)
98. Kim-Schulze S., McGowan K. A., Hubchak S. C., Cid M. C., Martin M. B., Kleinman H. K., Greene G. L., Schnaper H. W., Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996 94 6 1402 1407 2-s2.0-0029822927 (Pubitemid 26307272)
99. Jin X., Chen Y. C., Liu W. Q., Wang H. Y., Wang B., Zeng Z., Estradiol promote myocardial anglogenesis in a rat model of acute myocardial infarction through estrogen receptors. Sichuan Da Xue Xue Bao Yi Xue Ban 2008 39 3 398 401 2-s2.0-44449097607
100. Hamilton K. L., Lin L., Wang Y., Knowlton A. A., Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression. Physiological Genomics 2008 32 2 254 263 2-s2.0-38749120250 10.1152/ physiolgenomics.00039.2007 (Pubitemid 351186331)
101. Pechenino A. S., Lin L., Mbai F. N., Lee A. R., He X., Stallone J. N., Knowlton A. A., Impact of aging versus estrogen loss on cardiac gene expression: estrogen replacement and inflammation. Physiological Genomics 2011 43 18 1065 1073 2-s2.0-80053163686 10.1152/physiolgenomics.00228.2010
102. Knowlton A. A., Lee A. R., Estrogen and the cardiovascular system. Pharmacology and Therapeutics 2012 135 1 54 70 2-s2.0-84859795585 10.1016/j.pharmthera.2012.03.007
103. Gopal S., Garibaldi S., Goglia L., Polak K., Palla G., Spina S., Genazzani A. R., Genazzani A. D., Simoncini T., Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1). Molecular Human Reproduction 2012 18 8 410 416 10.1093/molehr/gas011
104. Losordo D. W., Isner J. M., Estrogen and angiogenesis: a review. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 1 6 12 2-s2.0-0035165485 (Pubitemid 32061922)
105. Greb R. R., Heikinheimo O., Williams R. F., Hodgen G. D., Goodman A. L., Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo. Human Reproduction 1997 12 6 1280 1292 2-s2.0-0031005638 (Pubitemid 27273561)
106. Rusnati M., Casarotti G., Pecorelli S., Ragnotti G., Presta M., Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometrium. Gynecologic Oncology 1993 48 1 88 93 2-s2.0-0027396004 10.1006/gyno.1993.1014 (Pubitemid 23056191)
107. Cid M. C., Kleinman H. K., Grant D. S., Schnaper H. W., Fauci A. S., Hoffman G. S., Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. Journal of Clinical Investigation 1994 93 1 17 25 2-s2.0-0028153564
108. Cid M. C., Schnaper H. W., Kleinman H. K., Estrogens and the vascular endothelium. Annals of the New York Academy of Sciences 2002 966 143 157 2-s2.0-0036303127 (Pubitemid 34729170)
109. Reed M. J., Edelberg J. M., Impaired angiogenesis in the aged. Science of Aging Knowledge Environment 2004 2004 7 pe7 2-s2.0-1542348214
110. Jayachandran M., Litwiller R. D., Owen W. G., Miller V. M., Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric 2009 12 2 177 184 2-s2.0-61949284701 10.1080/13697130802488607
111. Rank A., Nieuwland R., Nikolajek K., Rösner S., Wallwiener L., Hiller E., Toth B., Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women. Archives of Gynecology and Obstetrics 2012 285 4 1035 1041 2-s2.0-80053511693 10.1007/s00404-011-2098-0
112. Forest A., Pautas E., Ray P., Bonnet D., Verny M., Amabile N., Boulanger C., Riou B., Tedgui A., Mallat Z., Boddaert J., Circulating microparticles and procoagulant activity in elderly patients. Journals of Gerontology A 2010 65 4 414 420 2-s2.0-77950474408 10.1093/gerona/glp187
113. Simak J., Gelderman M. P., Yu H., Wright V., Baird A. E., Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. Journal of Thrombosis and Haemostasis 2006 4 6 1296 1302 2-s2.0-33646812544 10.1111/j.1538-7836.2006.01911.x
114. Williams J. B., Jauch E. C., Lindsell C. J., Campos B., Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. Academic Emergency Medicine 2007 14 8 685 690 2-s2.0-34447327229 10.1197/j.aem.2007.04.009 (Pubitemid 47058288)
115. Carcaillon L., Alhenc-Gelas M., Bejot Y., Spaft C., Ducimetière P., Ritchie K., Dartigues J., Scarabin P. Y., Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the three-city cohort study. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 6 1445 1451 2-s2.0-79957517864 10.1161/ATVBAHA.111. 223453
116. Hoekstra T., Geleijnse J. M., Kluft C., Giltay E. J., Kok F. J., Schouten E. G., 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 2003 34 12 2822 2828 2-s2.0-0345550538 10.1161/01.STR. 0000098004.26252.EB (Pubitemid 37517749)
117. Björck H. M., Eriksson P., Alehagen U., de Basso R., Ljungberg L. U., Persson K., Dahlström U., Länne T., Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure. The American Journal of Hypertension 2011 24 7 802 808 2-s2.0-79959365714 10.1038/ajh.2011.63
118. Steogonekpień E., Stankiewicz E., Zalewski J., Godlewski J., zmudka K., Wybrańska I., Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Archives of Medical Research 2012 43 1 31 35 2-s2.0-84859231098 10.1016/j.arcmed.2012.01.006
119. Sinning J., Losch J., Walenta K., Böhm M., Nickenig G., Werner N., Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. European Heart Journal 2011 32 16 2034 2041 2-s2.0-79961045475 10.1093/eurheartj/ehq478
120. Amabile N., Heiss C., Real W. M., Minasi P., McGlothlin D., Rame E. J., Grossman W., de Marco T., Yeghiazarians Y., Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. The American Journal of Respiratory and Critical Care Medicine 2008 177 11 1268 1275 2-s2.0-44449177817 10.1164/rccm.200710-1458OC (Pubitemid 351860937)